Journal of the National Comprehensive Cancer Network

Article	Citations
CLO23-035: Expression of PD-L1 Through Evolution Phase From Pre-Invasive to Invasive Lung Adenocarcinoma	1129
HSR23-103: Pancreatic Cancer: The Impact of Early Connectivity and Coordination of Care on Retention and Time to Treat	798
CLO23-045: A Prospective Interventional Study to Assess the Response of Systemic Chemotherapy in Aggressive, Recurrent Giant Cell Tumor	681
CLO23-043: Optimal Interval Between Immune Therapy and Targeted Therapy With Sotorasib in Patients With KRAS G12C Mutant Non–Small Cell Lung Cancer	640
My Report Card	509
Highlights of the NCCN Oncology Research Program	498
EHR-Integrated Patient-Reported Outcomes in Ambulatory Oncology: A Critical Opportunity for Timely and Targeted Palliative Care	449
HSR24-169: Autonomic Symptoms May Suggest Paraneoplastic Neurological Syndromes in Small Cell Lung Cancer	438
HSR24-153: Real-World Clinical Outcomes of First-Line Therapies and Treatment Regimens for BRAF-Mutant Advanced/Metastatic Melanoma: Retrospective Observational Study	435
CRE24-049: Extrapulmonary Small Cell Carcinoma of Gallbladder Presenting as Acute Cholecystitis	411
HSR24-127: Rectal Cancer Disparities in Age and Overall Survival Among American Indian and Alaska Native Vs Non-Hispanic White Populations	401
CLO24-055: Outcomes With Sacituzumab Govitecan in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis	365
EPR24-113: The Role of Social Determinants of Health in Gastrointestinal Cancer Outcomes in the United States Context: A Systematic Review	334
HSR24-163: Comparative Assessment of Social Determinants of Health in Community and Academic Hospitals for Patients Diagnosed With Hepatocellular Carcinoma	333
Relapsed/Refractory CLL/SLL: Overcoming Resistance to Covalent BTKi and/or BCL2 Inhibitors	263
Highlights of the NCCN Oncology Research Program	249
NCCN News	235
Highlights of the NCCN Oncology Research Program	225
A New Administration and JNCCN	191
Oncology Survivorship Care Clinics: Design and Implementation of Survivorship Care Delivery Systems at NCCN Member Institutions	184
BPI25-005: Molecular Biomarker Testing Patterns and Turn-Around Time in US Patients With Advanced Non-Small Cell Lung Cancer	181
BPI25-019: Empirical Study to Estimate Real World Impact of Delay in EGFR Testing on Healthcare Resource Utilization and Cost Burden Among Early-Stage NSCLC Patients	180
BIO25-027: Addressing Early Diagnosis Challenges: Utilizing C the Signs Clinical Decision Support Platform for Pancreatic Cancer Risk Assessment	151
HSR24-152: Patient-Reported Outcome (PRO) Data in Oncology NDAs Approved by the FDA (2018–2021): A Review of Criticism and Concerns in Comments From Regulators	150
EPR24-099: Clinical and Epidemiological Characterization of the Oncologic Population in a Third Level Hospital in Northeastern Mexico	137

YIA24-005: MAIT Cells are Reduced in Anorectal Mucosal Melanomas Compared to Cutaneous Melanoma GI Metastases	129
CLO24-060: Organomegalies as a Predictive Indicator of Leukemia Cutis in the Patients With Acute Myeloid Leukemia	128
The Association of Extended Venous Thromboembolism Prophylaxis and Venous Thromboembolism After Cancer Surgery	121
Advances in the Treatment of Recurrent Ovarian Cancer and Rare Malignant Ovarian Germ Cell Tumors	116
Association of Polypharmacy and Potentially Inappropriate Medications With Frailty Among Older Adults With Blood Cancers	116
NCCN News	115
Academic Oncology at a Crossroads: Rebuilding a Sustainable Career Path	114
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025	111
Hemithyroidectomy Versus Total Thyroidectomy for Sporadic Medullary Thyroid Cancer: A Chinese Nationwide Large-Scale Cohort Study	106
Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology	104
HSR25-181: Assessment of Content Validity of the Functional Assessment of Cancer Therapy – Cutaneous T-Cell Lymphoma (FACT-CTCL)	101
Statin Use During Concurrent Chemoradiotherapy for Advanced Nasopharyngeal Cancer	101
HSR25-141: Adolescent and Young Adult Cancer Patients: Our Most Financially Vulnerable Demographic	100
CLO25-078: Deciphering Risk of Early Biochemical Recurrence in Prostate Cancer Prior to Definitive Therapy	97
EPR25-128: Epidemiology of Olfactory Neuroblastoma: A SEER Stat Review	95
Highlights of the NCCN Oncology Research Program	87
Patient-Reported Symptom Complexity and Acute Care Utilization Among Patients With Cancer: A Population-Based Study Using a Novel Symptom Complexity Algorithm and Observational Data	81
Evaluation of NCI-Designated Cancer Center and Comprehensive Cancer Center Survivorship-Focused Websites: Information Provided and Accessibility	80
EPR25-138: Glioblastoma Multiforme: A SEER STAT Analysis of Epidemiological, Laterality, and Anatomical Prognostic Indicators	79
EPR26-166: Food Insecurity and Healthcare Utilization Among Cancer Survivors - Pre and Post COVID-19	71
Empowering Care Teams: Redefining Message Management to Enhance Care Delivery and Alleviate Oncologist Burnout	71
BPI26-019: Comparison of Dosimetric Parameters of Organs at Risk Using Two Different Methods of Contouring in Head Neck Cancer Volumetric Arc Radiotherapy	69
CLO26-131: Hematologic–IHC Prognostic Score for Therapeutic Prioritization in Breast Cancer: Multicenter Validation in Peru (2010–2020)	67
HSR26-231: Diagnostic Performance of the Bexa™ Breast Exam for Detection of Breast Masses: A Prospective Single-Center Study	62
HSR26-266: Navigating the Burden of Cure: Defining Survivorship Pathways in Head and Neck Cancer	56
EPR26-152: GLP-1 and Dual Agonists and the Incidence of Skin Cancer: Evidence from Randomized Controlled Trials	55
CGE26-135: Differential Germline Mutation Spectrum Analysis in Familial and Inherited Breast Cancer Patients in Pakistan	53
CLO26-089: Open Radical Cystectomy in the Current Era: Perioperative Outcomes From a Single Institutional Experience	53
CLO26-115: Association Between Geriatric Assessment Variables and Treatment Completion in Older Adults With Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy and Immunotherapy: The MSKC	53
QIM26-305: Central Fill Optimization to Reduce Drug Waste and Enhance Multidisciplinary Workflow Within an Ambulatory Infusion Suite	52
Proportion of Gleason Score ≥8 Prostate Cancer on Biopsy and Tumor Aggressiveness in Matched Cohorts of East Asian and Non-East Asian Men	48
Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II Trial	44
QIM24-176: Technology’s Impact on Implementing the NCCN Distress Thermometer in a Community-Based Oncology Clinic	43
Adult Acute Lymphocytic Leukemia: Strategies for Selection of Consolidation Therapy	42
QIM23-140: Health Care Satisfaction Among Cancer Patients Undergoing Radiotherapy: A Tunisian Center Experience	40
New Treatment Options for Patients With Bladder Cancer	39
Cancer Screening and Surveillance Testing for Older Adult Cancer Survivors	39
Out in the World Again	38
EPR25-133: Frequency and Pattern of 30-Day Readmissions in Cancer Patients With C.difficile Infection	35
Optimizing BTK Inhibition in Waldenström Macroglobulinemia	35
HSR25-151: EPIC Patient Portal Functionality: An Equity Analysis in Vulnerable Cancer Patients	35
Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary	35
HSR25-166: Linking COVID-Related Distress and Mental Health Service Utilization Among Allogeneic Hematopoietic Stem Cell Transplant Patients	34
HSR25-148: The State of Lung Cancer in Alabama	34
HSR25-202: Epidemiology and Outcomes of Ventricular Arrhythmias in Patients With Hypercalcemia of Malignancy: A Population-Based Study	33
21-Gene Recurrence Score and Survival Outcomes in the Phase III Multicenter TAILORx Clinical Trial	32
CRE25-044: A Case Series of Immunotherapy-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis	31
CLO23-032: Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting	31
CLO23-059: HDR-ICR Brachytherapy With Solo Anesthesia Administration as a Resource-Effective and Patient-Safe Method in Cancer Cervix	31
Hope and Uncertainty in Advanced Cancers	30

CRE26-067: Treatment Response to Lenvatinib in Metastatic Adenoid Cystic Triple Negative Breast Cancer: A Case Report	30
EPR26-176: BRAF-Mutated Hairy Cell Leukemia: Survival Trends and Treatment Patterns Using SEER Database	29
CLO26-110: Novel Targeted Therapies for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: A Systematic Review	28
CLO26-092: Real-World Use of Eflapegrastim in 14-Day Chemotherapy Cycles/Dose-Dense Regimens	28
BPI26-024: Hypofractionated Radiation Therapy for Breast Cancer: A Unit Review in Alignment With International Guidelines	27
QIM26-295: A Literature Review on the Effects of Testosterone Replacement Therapy in Men With a History of Radical Prostatectomy for Prostate Cancer	27
HSR26-200: Chronicled Experiences of Breast Cancer: Analysing Adjuvant Endocrine Therapy on TikTok	27
CRE26-056: Multidisciplinary Management Leading to Cure in Poor-Risk Stage IIIC Non-Seminomatous Germ Cell Tumor (NSGCT) With Acute Kidney Injury, Dialysis Dependent: A Case Report and Literature Revi	27
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study	26
Proton Pump Inhibitors in the Era of Immunotherapy: A Risk Worth Taking?	26
Role of Radiation Therapy in Retroperitoneal Sarcoma	26
End-of-Life Care Among Patients With Neuroendocrine Tumors: Underutilization of Palliative Care and Racial Disparities	26
Worse Survival and Gastrointestinal Toxicity Outcomes Among Patients Receiving Proton Pump Inhibitors During Checkpoint Inhibitor Therapy	25
Telehealth Geriatric Assessment and Supportive Care Intervention (GAIN-S) Program: A Randomized Clinical Trial	25
NCCN News	25
Enhancing Readability of Online Patient-Facing Content: The Role of AI Chatbots in Improving Cancer Information Accessibility	25
Urinary Circular RNA Panels to Detect HBV-Related Hepatocellular Carcinoma: A Multicenter, Large-Scale, Case-Control Study	24
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022	24
Social Determinants of Health Are Associated With Treatment Receipt and Mortality in Patients With Hepatocellular Carcinoma	24
Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology	24
Long-Term Tumor Stability After First-Line Treatment With Larotrectinib in an Infant With NTRK2 Fusion–Positive High-Grade Glioma	23
Influence of Food With Different Fat Concentrations on Alectinib Exposure: A Randomized Crossover Pharmacokinetic Trial	23
NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025	22
First, Do No Harm	22
Impact of a Comprehensive Financial Navigation Intervention to Reduce Cancer-Related Financial Toxicity	22
Association Between Patient-Reported Outcomes–Derived Symptom Complexity and Overall Survival Among Patients With Cancer	22
Management of Patients With Resectable and Metastatic Non–Small Cell Lung Cancer	21
Perioperative Management of Anticoagulation and Antithrombotic Therapy	21
NCCN News	21
Updates to the Management of Patients With Relapsed or Refractory Indolent Follicular and Marginal Zone Lymphomas	21
NCCN News	21
CGE23-071: Real World Data on the Implementation of a Hereditary Hematological Myeloid Malignancy Workflow: Experience of a Single Academic Medical Center	21
HSR24-166: Implementation of an Integrated Supportive Care Medicine Consultation Service Within a Gastrointestinal Cancer Clinic: Timeliness of Referrals and Patient Access	20
Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology	20
Pancreatitis and Hyperlipasemia in the Setting of Immune Checkpoint Inhibitor Therapy	20
YIA25-001: Molecular Residual Disease (MRD) Guided Adjuvant Therapy In Renal Cell Carcinoma (RCC) - The MRD GATE RCC Study	20
The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALL	20
EPR24-101: Characteristics of Individuals With Early-Onset GI Cancers in the Southeastern US	20
CRE26-068: Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Masquerading as Cholestatic Jaundice: Early Diagnostic Recognition Enhanced by Artificial Intelligence	20
HSR24-171: Utilizing Diverse Enrollment to Validate the DELFI Fragmentome Test for Advancing Lung Cancer Screening	19
BIO26-041: Medical Bioinformatics–Enabled Reminders Improve Pre-Visit Lab Readiness in a Hematology Clinic: A PDSA Quality Improvement Project	19
NCCN Policy Summit: Cancer Across Geography	19
CLO26-112: Durvalumab Versus Pembrolizumab With Gemcitabine and Cisplatin in First-Line Treatment of Advanced Biliary Tract Cancer: A Real-World Comparative Effectiveness Analysis	19
Changes for JNCCN in 2025	18
HSR25-172: Meta-Analysis of Phase 3 Randomized Controlled Trials to Evaluate the Incidence of Infectious Adverse Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Belantamab Ma	18
HSR25-153: Patient Preferences and Willingness to Accept Trade-Offs for a Favorable Treatment Response Among Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer	18
QIM25-230: Enhancing Communication Through Interprofessional Goal Concordant Care Training	18
QIM25-228: Utilizing Patient and Provider Perspectives in Psycho-Oncology Program Development and Quality Improvement	18
HSR25-204: Clinical Characteristics and Prognosis Associated With Low PSA in Patients With De Novo Metastatic Hormone Sensitive Prostate Cancer	18
A Taxonomy for Assessing Real-World Targeted Cancer Therapy Options in the Context of Broad Genomic Profiling	17
Erratum to: Revised Perspective on the AJCC Staging System for Medullary Thyroid Cancer: A Study of Two Nationwide Cohorts	17
CLO25-102: Survival Outcomes in Breast Cancer Patients With Diseased Axillary Lymph Nodes: The Role of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.	17
BIO25-024: Real-Time Clinical Trial Data Library in Non-Small Cell Lung (NSCLC), Prostate (PC), and Breast Cancer (BC) to Support Informed Treatment Decisions: Now a Reality With a Fine-Tuned Large La	17
HSR25-190: Clinical Experience With Immunotherapy in Advanced Solid Tumors – Real World Data From India	17
Machine Learning–Based Early Warning Systems for Acute Care Utilization During Systemic Therapy for Cancer	17
Modern Radiation Therapy Techniques for Vaginal Carcinoma	17
Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral	17
BIO25-026: Innovating a Digital Patient Navigation Platform (DPNP) to Help Patients With Melanoma Access Multidisciplinary Cutaneous Oncology Care	17
First-Line PD-1 Blockade Combined With Chemotherapy for Stage IV Penile Squamous Cell Carcinoma: A Multicenter Retrospective Study	17
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025	16
Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia Among Patients With Solid Tumors	16
Disparate Use of Chemoradiation in Elderly Patients With Localized Anal Cancer	16
Biomarker Testing, Treatment, and Outcomes in Patients With Advanced/Metastatic Non–Small Cell Lung Cancer Using a Real-World Database	16
Key Performance Indicators and Metrics for the Implementation of an Oral Chemotherapy Adherence Program	16
Mitigating the Risk of Aberrant Use of Opioids in Patients With Cancer Pain	16
Promising Practices to Reduce the Impact of Drug Shortages on Cancer Care	16
Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice	15
Integrating Immune Therapies for the Treatment of Multiple Myeloma	15
Adult Cancer Pain, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology	15
Erratum	15
The Value and Process of Inclusion: Using Sensitive, Respectful, and Inclusive Language and Images in NCCN Content	15
Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology	15
High-Risk Prevention Programs: Identifying Services for High-Risk Patients	14
BPI23-016: Interventional Pain Management in Outpatient Setting for Cancer Patients: A Review of Literature	14
NCCN News	14
HSR23-121: Assessment of Sustained MRD Negativity and Reversion in Real-World Multiple Myeloma Patients Using NGS (clonoSEQ Assay)	14
Addressing Racial Inequity in Cancer Care: Self-Awareness Among Oncology Professionals	14
CLO23-068: Effectiveness and Toxicity of Cetuximab With Concurrent Radiotherapy in Locally Advanced Cutaneous Squamous Cell Skin Cancer: A Case Series	13
CRE25-043: Treatment of HER2-Positive Breast Cancer With Leptomeningeal Metastases With Intrathecal Trastuzumab	13
Highlights of the NCCN Oncology Research Program	13

EPR23-080: Oral Cancer Screening Among the Rural Indians—A Community Based Prospective Study	13
HSR24-126: “Share the Fear”: Communication Concerns of Parents With Cancer With Dependent Children for Their Co-Parent: A Qualitative Study	13
CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches	13
CLO23-039: Safety Profile of Sonic Hedgehog Inhibitors in Basal Cell Carcinoma: A Systematic Review	13
Abstracts From the NCCN 2023 Annual Conference	13
CRE25-041: Pneumocephalus in the Setting of Endometrial Adenocarcinoma: A Case Report	13
CRE24-038: Neuroendocrine Tumor of the Gallbladder: A Case Report and Literature Review.	12
HSR24-150: Real-World Treatment Patterns of Selumetinib Among Patients With Neurofibromatosis Type I and Plexiform Neurofibroma in the United States	12
HSR24-148: Outcome of Positron Emission Tomography–Computed Tomography Staging in Breast Cancer Patients Having Neo-Adjuvant Systemic Therapy	12
Authors’ Reply to the Letter to the Editor by Liu and Kesselheim	12
BPI24-010: Temporary Toilet Lids Minimize Contamination of Bathroom Surfaces With Hazardous Drugs	12
HSR24-173: Reaching Unmet Needs of Lung Cancer Patients Through Hope Totes and Educational Meetings	12
Reaching Populations to Address Disparities in Cancer Care Delivery: Results From a Six-Site Initiative	12
Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair–Deficient Colorectal Cancer	11
Therapy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma in Children, Adolescents, and Young Adults	11
Unusual Adverse Events in a Patient With BRAF-Mutated Non–Small Cell Lung Cancer Treated With BRAF/MEK Inhibition	11
Comparative Effects of Hospital Volume and Safety-Net Status on Treatment Use and Outcome Measures in Hepatocellular Carcinoma	11
Treatment Updates for Small Cell Lung Cancer	11
NCCN News	11
Life Years Gained From the FDA Accelerated Approval Program in Oncology: A Portfolio Model	11
NCCN Guidelines for Central Nervous System Cancers: Updates in the Treatment of Adult Patients With Glioma	11
HSR25-203: Cost-Effectiveness Evaluation of Bruton Tyrosine Kinase Inhibitor (BTKi) Treatments Among Medicare Patients With Chronic Lymphocytic Leukemia (CLL) in First-Line (1L) and Relapsed/Refractor	11
Aligning With the National Cancer Plan	11
Updates to Management of Multiple Myeloma	11
Navigating the Challenges: Effective Management of Toxicities in CAR T-Cell Therapies	11
Potential Biomarkers in Thymic Epithelial Tumors: Thymoma and Thymic Carcinoma	10
HSR26-211: Extending the Reach: A Narrative Review on Mindfulness-Based Interventions for African American Caregivers and Future Applications in Behavioral Oncology	10
CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-Analysis	10
CRE26-054: Germline BARD1 Mutation and Exceptional Response to FOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) – A Case Report	10
CLO26-076: Prognostic Outcomes in Resected Pancreatic Cancer Treated With Neoadjuvant Chemotherapy Alone: Impact of Integrated Pathologic Score	10
Highlights of the NCCN Oncology Research Program	10
CLO26-119: Clinical Outcomes of Gastric Outlet Obstruction Among Patients With Pancreatic Cancer Stratified by Sex: A Multicenter Analysis Using the Nationwide Readmissions Database (NRD)	10
Current and Emerging Biomarkers: Impact on Risk Stratification for Neuroblastoma	10
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022	9
QIM23-133: Aligning NCCN Criteria With Testing Workflows Using a Novel Database Application (Criterion™)	9
HSR23-113: Patient and Provider Perspectives on How COVID-19 Impacted Melanoma Care Delivery	9
HSR25-144: Clinical Outcomes for Leukemia Patients Following Hematopoietic Stem Cell Transplant: An Analysis of the National Inpatient Sample	9
Quality of Life Among Patients With Locally Advanced Pancreatic Cancer: A Prospective Nationwide Multicenter Study	9
Immunoglobulin Light Chain Amyloidosis: Diagnosis and Risk Assessment	9
CLO23-040: Electrocardiographic Findings in Cancer Patients Receiving Chemotherapy From the Colombian Coffee Triangle Region	9
Highlights of the NCCN Oncology Research Program	9
HSR23-112: Disease Burden and Treatment Patterns in Patients Diagnosed With HER2- Metastatic Gastric/Gastroesophageal Junction Cancer (mG/GEJC)	9
Revisiting the Association of ECOG Performance Status With Clinical Outcomes in Diverse Patients With Cancer	9
CLO23-026: Hydrogel Slope and Optimization of Prostate-Rectal Hydrogel Placement	9
HSR25-175: Meta-Analysis of Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Venous Thromboembolism (VTE) and Immune-Related Adverse Events (iRAEs) in Patients With Primary Advanced or	9
Optimizing Electronic Secure Messaging to Mitigate Oncologist Burnout	9
QIM25-227: Evaluating Dosimetric Differences in Head and Neck Cancer Treatment: A RapidArc Approach With Flattening Filter-Free vs. Filtered Beams	8
NCCN News	8
EPR24-117: A Comprehensive Examination of Disparities in Metastatic Breast Cancer Incidence: Race, Income and Geography	8
Association Between Cancer Center Accreditation and Compliance With Price Disclosure of Common Oncologic Surgical Procedures	8
Updates in the Management of Biliary Tract Cancers	8
Letter to the Editor: Methodological Limitations in Breast Cancer Survivorship Research: Beyond Linear Regression	8
CLO25-083: Immune-Related Adverse Events in Women With Early and Advanced Triple-Negative Breast Cancer Treated With Pembrolizumab: A Multi-Center Analysis	8
QIM24-178: Managing Pharmaceutical Costs in the Oncology Care Model	8
QIM25-223: Acceptability, Facilitators, and Barriers to the Implementation of Screening and Brief Intervention for Alcohol Counseling in the Oncology Setting	8
Incident Cancer Detection During Multiple Waves of COVID-19: The Tsunami After the Earthquake	8
CLO25-070: Effects and Mechanisms of CD16+/-NK Cells on Ovarian Malignant Tumor Cells Platinum-Based Drug Responsiveness in Tumor Microenvironment	8
Infant-Type Hemispheric Gliomas: A Review of Clinical, Radiologic, Histopathologic, and Molecular Features	8
EPR25-137: Epidemiology and Prognostication of Malignant Glomus Tumor	8
BPI24-013: Microwave Ablation Versus Resection Versus Stereotactic Body Radiation Therapy of Stage IA Non–Small Cell Lung Cancer in US Veterans	8
Mitigating Inequities? Or Compromising Patient Privacy and Safety?	8
Symptom Burden and Survivorship Care for Patients With Prostate Cancer on Androgen Deprivation Therapy	8
NCCN News	8
BPI26-016: Strengthening Guideline Compliant Care Delivery in a Safety Net Hospital Through Artificial Intelligence (AI) Enabled Technology Solutions	8
BIO26-046: Validating an LLM for Detecting Enrollment Disparities in Breast Cancer Trials	7
Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer	7
Cardiovascular Adverse Events and Associated Costs of CDK4/6 Inhibitors in Patients With Breast Cancer	7
CRE24-053: Brown Fat Adipose Tissue (BAT) Activation Mimicking Lymphoma-Associated Lymphadenopathy	7
EPR26-192: Multivariate Survival Analysis and Prevalence Disparities in Ewing Sarcoma: A SEERStat Based Retrospective Study	7
Associations Among Optimal Lung Cancer Treatment, Clinical Outcomes, and Health Care Utilization in Patients Who Underwent Comprehensive Genomic Profiling	7
CRE24-042: Microgranular Acute Promyelocytic Leukemia Presenting as Recurrent Stroke and Isolated Neutropenia	7
Immunotherapy-Based Neoadjuvant Treatment of Advanced Microsatellite Instability–High Gastric Cancer: A Case Series	7
CLO24-058: Evaluation of Aromatherapy With Lavender Oil During the Perioperative Period of Benign Prostate Hyperplasia: A Randomized Placebo Controlled Clinical Observation	7
Referral, Uptake, and Outcome of Genetic Counseling and Testing in Patients With Early-Onset Colorectal Cancer	7
HSR26-197: Body Mass Index and Chemotherapy Induced Anemia in Head and Neck Cancer: Impact of Hemoglobin and Weight Loss During Treatment	7
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024	7
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology	7
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024	7
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma	7
EPR26-150: Evaluating Pre-operative Imaging Accuracy in Breast Cancer Staging: Insights From Real-World	7
I Cannot Afford This!	6
YIA23-006: BE-EPIC: Behavioral Economic Interventions to Embed Palliative Care in Community Oncology	6
Rurality Status and Cardiovascular Events/Survival in Older Men With Prostate Cancer	6
Advancing Health Equity in Cancer-Related Distress: Lessons Learned From the COVID-19 Pandemic on Leveraging Digital Tools and Future Directions	6
EPR23-082: Patient Awareness of Elevated Breast Cancer Risk After Routine Screening Mammogram and Risk Notification	6
Failure Doesn’t Feel Good!	6
HSR25-168: Survival Analysis for Early Onset and Very Early Onset Colon Cancer Using National Cancer Database (NCDB) 2004-2021	6
Association of HOXB13 G84E With Prostate Cancer Among 592,158 Men	6
BPI24-026: Utilization of ExoDx Prostate Test for Prostate Cancer Risk Stratification in the African American Population	6
Letter to the Editor: The Role of Skin Biopsy in the Management of Immune Checkpoint Inhibitor Toxicity	6
Revolutionizing Hematologic Cancer Treatment: The Promise of Bispecific T-Cell Engagers	6
Authors’ Reply to the Letter to the Editor by Foote et al: Revisiting a “Revised Perspective on the American Joint Committee on Cancer’s Staging System for Medullary Thyroid Cancer”	6
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology	5
BIO26-048: A Meta-Analytic Evaluation of Efficacy and Safety Between Ide-cel and Cilta-cel in Relapsed/Refractory Multiple Myeloma Based on Clinical Trial and Real-World Data	5
CLO26-083: Potential BMI-Dependent MACE Risk in Postmenopausal Breast Cancer Patients Treated With CDK4/6 Inhibitors: A Mayo Clinic Platform Study	5